EUnetHTA calls for Patient Input – Joint Assessment on a medicinal product for UC
EUnetHTA deems patient involvement very important in the production of Joint Assessment reports. We recognise that patients and those who support them have unique knowledge about what it is like to live with a specific disease or medical condition. We believe patient groups can help us understand patients’ unique perspectives by collecting and presenting patients’ and carers/care-givers’ views and experiences by engaging with a wide range of patients. They can describe advantages and disadvantages of medicinal treatments based on patients’ experiences and what patients value from a new treatment.
Go to call to open call: click here
EUnetHTA was established to create an effective and sustainable network for HTA across Europe – it works together to help develop reliable, timely, transparent and transferable information to contribute to HTA’s in European countries. EUnetHTA supports collaboration between European HTA organizations that brings value at the European, national and regional level through: